Effect of raloxifene on fractures in postmenopausal women with or at risk for coronary heart disease: The raloxifene use for the heart (RUTH) study

被引：0
|
作者：
Ensrud, Kristine E.
Stock, John L.
Grady, Deborah
Barrett-Connor, Elizabeth
Mosca, Lori
Khaw, Kay-Tee
Zhao, Qingwen
Agnusdei, Donato
Dalsky, Gail P.
Cauley, Jane A.
机构：
[1] VAMC, Minneapolis, MN USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] Columbia Univ, Med Ctr, New York, NY USA
[7] Univ Cambridge, Sch Clin Med, Cambridge, England
[8] Eli Lilly & Co, Burlington, CT USA
[9] Univ Pittsburgh, Pittsburgh, PA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S234 / S235
页数：2
相关论文
共 50 条
  • [41] Adverse event risk assessment of raloxifene in postmenopausal women with osteoporosis
    Chlebowski, RT
    Cauley, JA
    Disch, D
    Secrest, RJ
    Mershon, JL
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 102S - 102S
  • [42] Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women
    Provinciali, Nicoletta
    Suen, Chen
    Dunn, Barbara K.
    DeCensi, Andrea
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1263 - 1272
  • [43] Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
    Clarkson, TB
    Anthony, MS
    Jerome, CP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03): : 721 - 726
  • [44] Resting electrocardiogram predicts mortality in postmenopausal women with coronary heart disease or with risk factors for coronary heart disease
    Schroeder, Klaus
    Wegscheider, Karl
    Wenger, Nanette K.
    Vettorazzi, Eik
    Schroeder, Rolf
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (06) : 749 - 757
  • [45] Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis
    Ensrud, K
    Genazzani, AR
    Geiger, MJ
    McNabb, M
    Dowsett, SA
    Cox, DA
    Barrett-Connor, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (04): : 520 - 527
  • [46] Effect of raloxifene hydrochloride on postmenopausal Japanese women with osteoporosis.
    Morii, H
    Orimo, H
    Taketani, Y
    Ishii, J
    Inoue, T
    Fujita, T
    Ohashi, Y
    Huster, WJ
    Lakshmanan, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T588 - T588
  • [47] The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women
    Naylor, K. E.
    Clowes, J. A.
    Finigan, J.
    Paggiosi, M. A.
    Peel, N. F. A.
    Eastell, R.
    BONE, 2010, 46 (03) : 592 - 597
  • [48] Effect of raloxifene after teriparatide treatment in postmenopausal women with osteoporosis
    Adami, S.
    Munoz-Torres, M.
    Econs, M. J.
    Sipos, A.
    Xie, L.
    Dalsky, G. P.
    McClung, M.
    Felsenberg, D.
    Brown, J. P.
    Brandi, M. L.
    San Martin, J.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S137 - S137
  • [49] Effect of estrogen and raloxifene on insulin sensitivity in postmenopausal women.
    Lee, CC
    Supiano, MA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S170 - S170
  • [50] Effect of treatment with raloxifene on mammographic breast density in postmenopausal women
    Silverio, Cristiane Donida
    Nahas-Neto, Jorge
    Petri Nahas, Eliana Aguiar
    de Oliveira Guazeelli, Marcos Mauricio
    Gomes, Marina Ayabe
    Dias, Rogerio
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (10): : 525 - 531
12345